Search
The noninvasive approach could help scientists track the movements of an important cell type that can influence the outcome of cancer treatment.
Hedvig Hricak, Chair of Memorial Sloan Kettering's Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors.
The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.
Scientists have learned that cutting a T cell’s brakes can have unexpected consequences.
From atherosclerosis and diabetes to liver fibrosis and osteoarthritis, senescent cells are at the root of many debilitating diseases. Scientists increasingly have them in the crosshairs.
Dr. Sadelain received the award for his research on chimeric antigen receptors (CARs) and their use in providing tailored cancer treatment to patients.
James P. Allison, Chair of the Immunology Program in the Sloan Kettering Institute, has been elected a member of the Institute of Medicine.
Memorial Sloan Kettering’s 41st annual ceremony recognized graduates and award winners with an online event.
A new study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia.
New findings from researchers at the Sloan Kettering Institute suggest that cancer causes may be lurking in the molecule that bridges DNA and protein.